Skip to content
Clinical Trials – home
EstoniaBack to Estonia

Clinical trials in Kohtla-Jarve Linn

6 clinical trials in Kohtla-Jarve Linn, Estonia. Every trial is listed in the EU Clinical Trials Register and updated daily.

EstoniaOur site in EstoniaKliinilisedUuringud.ee(opens in a new tab)
Kohtla-Jarve Linn at a glance
6
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

6 trials in Kohtla-Jarve Linn

Open in trial search

VMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk

InvestigationalNo placebo
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:VMX-C001
  • Sponsor:VarmX B.V.

Bladder cancer

Not recruiting

Study on UGN-102 (Mitomycin) for Treating Low Grade Non-Muscle Invasive Bladder Cancer in Patients at Intermediate Risk of Recurrence

InvestigationalNo placebo
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Mitomycin
  • Sponsor:Urogen Pharma Ltd.

Bladder cancer

Not recruiting

Study on UGN-103 (Mitomycin) for Treating Low Grade Nonmuscle Invasive Bladder Cancer in Patients at Intermediate Risk of Recurrence

InvestigationalNo placebo
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Poloxamer 407
  • Sponsor:Urogen Pharma Ltd.

Urinary tract infection+1

Not recruiting

Study on the Effectiveness and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam for Adults with Complicated Urinary Tract Infections or Acute Pyelonephritis

Registered drugNo placebo
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Aztreonam
  • Sponsor:Meiji Seika Pharma Co. Ltd.

Title: Comparison of oral tebipenem pivoxil versus intravenous imipenem-cilastatin in adults with complicated urinary tract infection or acute pyelonephritis

Registered drug
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Cilastatin
  • Sponsor:Spero Therapeutics Inc.
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Aminocaproic Acid
  • Sponsor:AstraZeneca AB

Other cities in Estonia

The busiest research cities in the country

All 11 cities in Estonia

Clinical research in Kohtla-Jarve Linn

What the registry says about research in the country

01 Urological Oncology

Innovative research focusing on Non-Muscle Invasive Bladder Cancer treatments, evaluating novel therapeutic approaches for tumor ablation and management.

  • Bladder Cancer Treatment
  • Novel Therapeutic Formulations
  • Minimally Invasive Approaches

Multiple studies are exploring new treatment options to improve patient outcomes in early-stage bladder cancer.

02 Urinary Tract Infections

Clinical investigations into treatment options for complicated urinary tract infections and acute pyelonephritis, comparing various antibiotic combinations.

  • Advanced Antibiotic Therapies
  • Treatment Efficacy Studies
  • Infection Management

Research aims to establish more effective treatment protocols for severe urinary tract infections.

03 Diabetic Complications

Studies evaluating treatments for diabetic foot infections, comparing novel antibacterial agents to established therapies for improved patient care.

  • Infection Management
  • Comparative Drug Studies
  • Clinical Response Assessment

Focus on developing more effective treatments for moderate to severe diabetic foot complications.

04 Emergency Medicine

Research on anticoagulation reversal in urgent surgical situations, evaluating new agents for managing bleeding risks in patients on specific blood thinners.

  • Surgical Emergency Management
  • Bleeding Control
  • Patient Safety Protocols

Studies aim to improve safety during urgent procedures for anticoagulated patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.